- Assessing how genetic technologies are being integrated into health care and public health,
- Studying the clinical, public health, ethical, economic, legal, and societal implications of genetic and genomic technologies and applications,
- Identifying opportunities and gaps in research and data collection analysis efforts,
- Examining the impact of current patent policy and licensing practices on access to genetic technologies,
- Analyzing uses of genetic information in education, employment, insurance, and law,
- Serving as a public forum for discussion of issues raised by genetic and genomic technologies.
The main agenda item was an exploratory session on the implications of affordable whole-genome sequencing. The meeting also included updates and discussions on other issues SACGHS has been addressing, including the work of the Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children related to the retention and use of dried blood spot specimens from newborn screening. There was also an update from David R. Hunt, MD, FACS the Medical Officer at the Office of the National Coordinator for Health IT. This was a continuing discussion from his earlier presentation in February.
I will post meeting materials and rough draft transcripts as they are available.